Abstract
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant syndrome characterized by the predisposition to develop both peptic ulcer disease and a wide variety of endocrine tumors usually in adolescence and adulthood. Specifically, hyperplasia and/or tumors (most often adenomas) of the parathyroid, pancreatic islet cells, anterior pituitary, and adrenal cortical glands are classically described in affected individuals who have MEN1 (1,2). MEN1 is a highly penetrant disorder whose onset is generally during adult life with the occurrence of at least one, but most often more than one, of the aforementioned tumors. The age-related penetrance of this disorder based on analysis in 63 unrelated kindreds is 7, 52, 87, 98, 99, and 100% by 10, 20, 30, 40, 50, and 60 yr, respectively (3). The disorder is estimated to occur in approx 1 in 30,000 to 1 in 50,000 individuals. Most cases are associated with a positive family history of the disorder, but new germline mutations have been identified in a small percentage of individuals having a negative family history of the disorder but classic features of MEN1 (3–7).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
oReferences
Miller, J. A. and Norton, J. A. (1997) Multiple endocrine neoplasia. Cancer Treat. Res. 90, 213–225.
Thakker, R. V. (1998) Multiple endocrine neoplasia-syndromes of the twentieth century. J. Clin. Endocrinol. Metab. 83, 2617–2620.
Bassett, J. H., Forbes, S. A., Pannett, A. A., et al. (1998) Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am. J. Hum. Genet. 62, 232–244.
Agarwal, S. K., Kester, M. B., Debelenko, L. V., et al. (1997) Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum. Mol. Genet. 6, 1169–1175.
Giraud, S., Zhang, C. X., Serova-Sinilnikova, O., et al. (1998) Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. Am. J. Hum. Genet. 63, 455–467.
Sato, M., Matsubara, S., Miyauchi, A., Ohye, H., Imachi, H., Murao, K., and Takahara, J. (1998) Identification of five novel germline mutations of the MEN1 gene in Japanese multiple endocrine neoplasia type 1 (MEN1) families. J. Med. Genet. 35, 915–919.
Teh, B. T., Kytola, S., Farnebo, F., et al. (1998) Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. J. Clin. Endocrinol. Metab. 83, 2621–2626.
Yu, F., Venzon, D. J., Serrano, J., Goebel, S. U., Doppman, J. L., Gibril, F., and Jensen, R.T. (1999) Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syn-drome. J. Clin. Oncol. 17, 615–630.
Bystrom, C., Larsson, C., Blomberg, C., Sandelin, K., Falkmer, U., Skogseid, B., Oberg, K., Werner, S., and Nordenskjold, M. (1990) Localization of the MEN1 gene to a small region within chromosome 1 1q13 by deletion mapping in tumors. Proc. Natl. Acad. Sci. USA 87, 1968–1972.
Bale, S. J., Bale, A. E., Stewart, K., Dachowski, L., McBride, O. W., Glaser, T., Green, J. E. III, Mulvihill, J. J., Brandi, M. L., and Sakaguchi, K. (1989) Linkage analysis of multiple endocrine neoplasia type 1 with INT2 and other markers on chromosome 11. Genomics 4, 320–322 (published erratum appears in Genomics1989;5[1], 166).
Courseaux, A., Grosgeorge, J., Gaudray, P., et al. (1996) Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 1 1q13. The European Consortium on Men1 (GENEM 1; Groupe d’Etude des Neoplasies Endocriniennes Multiples de type 1). Genomics 37, 354–365.
Guru, S. C., Agarwal, S. K., Manickam, P., et al. (1997) A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. Genome Res. 7, 725–735.
Larsson, C., Skogseid, B., Oberg, K., Nakamura, Y., and Nordenskjold, M. (1988) Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332, 85–87.
Lemmens, I., Merregaert, J., Van de Ven, W. J., et al. (1997) Construction of a 1.2-Mb sequence-ready contig of chromosome 1 1q13 encompassing the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Genomics 44, 94–100.
Nakamura, Y., Larsson, C., Julier, C., Bystrom, C., Skogseid, B., Wells, S., Oberg, K., Carlson, M., Taggart, T., and O’Connell, P. (1989) Localization of the genetic defect in multiple endocrine neoplasia type 1 within a small region of chromosome 11. Am. J. Hum. Genet. 44, 751–755.
Knudson, A. G. (1971) Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68, 820–823.
Chandrasekharappa, S. C., Guru, S. C., Manickam, P., et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276, 404–407.
Guru, S. C., Goldsmith, P. K., Burns, A. L., Marx, S. J., Spiegel, A. M., Collins, F. S., and Chandrasekharappa, S. C. (1998) Menin, the product of the MEN1 gene, is a nuclear protein. Proc. Natl. Acad. Sci. USA 95, 1630–1634.
Agarwal, S. K., Guru, S. C., Heppner, C., et al. (1999) Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96, 143–152.
Bear, J. C., Briones-Urbina, R., Fahey, J. F., and Farid, N. R. (1985) Variant multiple endocrine neoplasia I (MEN IBurin): further studies and non-linkage to HLA. Hum. Hered. 35, 15–20.
Farid, N. R., Buehler, S., Russell, N. A., Maroun, F. B., Allerdice, P., and Smyth, H. S. (1980) Prolactinomas in familial multiple endocrine neoplasia syndrome type I: relationship to HLA and carcinoid tumors. Amer. J. Med. 69, 874–880.
Petty, E. M., Green, J. S., Marx, S. J., Taggart, R. T., Farid, N., and Bale, A. E. (1994) Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN1Burin) to chromosome 1 1q: evidence for a founder effect in patients from Newfoundland. Am. J. Hum. Genet. 54, 1060–1066.
Olufemi, S. E., Green, J. S., Manickam, P., et al. (1998) Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN 1 (MEN1Burin) in four kindreds from Newfoundland. Hum. Mutat. 11, 264–269.
Krawczak, M. and Cooper, D. N. (1997) The Human Gene Mutation Database. Trends Genet. 13, 121–122.
Lemmens, I., Van de Ven, W. J., Kas, K., et al. (1997) Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum. Mol. Genet. 6, 1177–1183.
Carling, T., Correa, P., Hessman, O., Hedberg, J., Skogseid, B., Lindberg, D., Rastad, J., Westin, G., and Akerstrom, G. (1998) Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 83, 2960–2963.
Debelenko, L. V., Brambilla, E., Agarwal, S. K., et al. (1997) Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum. Mol. Genet. 6, 2285–2290.
Farnebo, F., Teh, B. T., Kytola, S., Svensson, A., Phelan, C., Sandelin, K., Thompson, N. W., Hoog, A., Weber, G., Farnebo, L.O., and Larsson, C. (1998) Alterations of the MEN1 gene in sporadic parathyroid tumors. J. Clin. Endocrinol. Metab. 83, 2627–2630.
Görtz, B., Roth, J., Speel, E. J. M., Krähenmann, A., DeKrijger, R. R., Matias-Guiu, X., Muletta-Feurer, S., Rütmann, K., Saremaslani, P., Heitz, P. U., and Komminoth, P. (1999) MEN1 gene mutation analysis of sporadic adrenocortical lesions. Int. J. Cancer 80, 373–379.
Shou, W., Seol, J. H., Shevchenko, A., Baskerville, C., Moazed, D., Chen, Z. W. S., Jang, J., Shevchenko, A., Charbonneau, H., and Deshaies, R. J. (1999) Exit from mitosis is triggered by Tem1-dependent release of the protein phosphatase Cdc14 from nucleolar RENT complex. Cell 97, 233–244.
Prezant, T. R., Levine, J., and Melmed, S. (1998) Molecular characterization of the men1 tumor suppressor gene in sporadic pituitary tumors. J. Clin. Endocrinol. Metab. 83, 1388–1391.
Sawicki, M. P., Wan, Y. J., Johnson, C. L., Berenson, J., Gatti, R., and Passaro, E. Jr. (1992) Loss of heterozygosity on chromosome 11 in sporadic gastrinomas. Hum. Genet. 89, 445–449.
Vortmeyer, A. O., Boni, R., Pak, E., Pack, S., and Zhuang, Z. (1998) Multiple endocrine neoplasia 1 gene alterations in MEN1-associated and sporadic lipomas. J. Natl. Cancer Inst. 90, 398–399.
Teh, B. T., Esapa, C. T., Houlston, R., Grandell, U., Farnebo, F., Nordenskjold, M., Pearce, C. J., Carmichael, D., Larsson, C., and Harris, P. E. (1998) A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors. Am. J. Hum. Genet. 63, 1544–1549.
Zhuang, Z., Ezzat, S. Z., Vortmeyer, A. O., et al. (1997) Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res. 57, 5446–5451.
Korf, B. R. and Pagon, R. A. (1998) Overview of molecular genetic diagnosis (Unit 9.1), in Current Protocols in Human Genetics (Dracopoli, N. C., Haines, J. L., Korf, B. R., et al., eds.), John Wiley & Sons, New York, pp. 9.1.1–9.1.9.
Smooker, P. M. and Cotton, R. G. (1993) The use of chemical reagents in the detection of DNA mutations. Mutat. Res. 288, 65–77.
Bottema, C. D. and Sommer, S. S. (1993) PCR amplification of specific alleles: rapid detection of known mutations and polymorphisms. Mutat. Res. 288, 93–102.
Hayashi, K. (1991) PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl. 1, 34–38.
Loda, M. (1994) Polymerase chain reaction-based methods for the detection of mutations in oncogenes and tumor suppressor genes. Human Pathol. 25, 564–571.
Sidransky, D. (1997) Nucleic acid-based methods for the detection of cancer. Science 278, 1054–1058.
Liu, Q., Feng, J., and Sommer, S. S. (1996) Bi-directional dideoxy fingerprinting (Bi-ddF): a rapid method for quantitative detection of mutations in genomic regions of 300-600 bp. Hum. Mol. Genet. 5, 107–114.
Ben-Ezra, J. (1995) Amplification methods in the molecular diagnosis of genetic diseases. Clin. Lab. Med. 15, 795–815.
McPherson, R. (1995) Molecular basis of genetic disease and molecular methods. Clin. Lab. Med. 15, 779–794.
Wagener, C., Epplen, J. T., Erlich, H., Peretz, H., and Vihko, P. (1994) Molecular biology techniques in the diagnosis of monogenic diseases. Clin. Chim. Acta 225, S35–S50.
Grompe, M. (1993) The rapid detection of unknown mutations in nucleic acids. Nat. Genet. 5, 111–117.
Blaszyk, H., Hartmann, A., Schroeder, J. J., McGovern, R. M., Sommer, S. S., and Kovach, J. S. (1995) Rapid and efficient screening for p53 gene mutations by dideoxy fingerprinting (ddF). BioTech 18, 256–260.
Warren, W., Hovig, E., Smith-Sorensen, B., Borresen, A. L., Fujimura, F. K., Liu, Q., Feng, J., and Sommer, S. S. (1997) Detection of mutations by single-strand conformation polymorphism (SSCP) analysis and SSCP-hybrid methods (Unit 7.4), in Current Protocols in Human Genetics (Dracopoli, N. C., Haines, J. L., Korf, B. R., et al., eds.), John Wiley & Sons, New York, pp. 7.4.1–7.4.23.
Mashal, R. D., Koontz, J., and Sklar, J. (1995) Detection of mutations by cleavage of DNA heteroduplexes with bacteriophage resolvases. Nat. Genet. 9, 177–183.
Sekiya, T. (1993) Detection of mutant sequences by single-strand conformation polymorphism analysis. Mutat. Res. 288, 79–83.
Dracopoli, N., ed. (1994) Current Protocols in Human Genetics, John Wiley & Sons, New York.
Cotton, R.G. (1993) Current methods of mutation detection. Mutat. Res. 285, 125–144.
Thierfelder, L. (1998) Mutation detection by cycle sequencing (Unit 7.7), in Current Protocols in Human Genetics (Dracopoli, N. C., Haines, J. L., Korf, B. R., et al., eds.), John Wiley & Sons, New York, pp. 7.7.1–7.7.6.
Shuldiner, A. R., LeRoith, D., and Roberts, C. T. (1995) DNA sequence analysis, in Molecular Endocrinology: Basic Concepts and Clinical Correlations (Weintraub, B. D., ed.), Raven Press, New York, pp. 13–21.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc.
About this protocol
Cite this protocol
Petty, E.M., Glynn, M., Bale, A.E. (2001). Direct Molecular Diagnosis of Multiple Endocrine Neoplasia Type 1. In: Killeen, A.A. (eds) Molecular Pathology Protocols. Methods in Molecular Medicine™, vol 49. Humana Press. https://doi.org/10.1385/1-59259-081-0:227
Download citation
DOI: https://doi.org/10.1385/1-59259-081-0:227
Publisher Name: Humana Press
Print ISBN: 978-0-89603-681-9
Online ISBN: 978-1-59259-081-0
eBook Packages: Springer Protocols